|
|
||||||||
VASCULAR BIOLOGY
Department of Medicine, University of California, San Diego, La Jolla, California
Submitted 12 July 2006 ; accepted in final form 23 December 2006
| ABSTRACT |
|---|
|
|
|---|
transient receptor potential channel; reverse and forward mode; proliferation
In addition to the Ca2+-permeable channels in the plasma membrane, human PASMC also functionally express multiple Ca2+ transporters that allow Ca2+ to enter cell against the Ca2+ electrochemical gradient. The Na+/Ca2+ exchanger (NCX) is a ubiquitously expressed protein that transports Ca2+ across the plasma membrane based on the transmembrane electrochemical gradient of Na+ and Ca2+ (9). Na+/Ca2+ exchangers operate in either a forward (3 Na+ entry and 1 Ca2+ exit for NCX; or 4 Na+ entry and 1 Ca2+ and 1 K+ exit for NCKX) or reverse (3 Na+ exit and 1 Ca2+ entry or 4 Na+ exit and 1 Ca2+ and 1 K+ entry) mode based on the transmembrane Na+ and Ca2+ (and K+) concentration gradients and membrane potential (9). Since the stoichiometry of the NCX family of Na+/Ca2+ exchanger proteins is 3 Na+ per 1 Ca2+, the [Ca2+]cyt determined by the NCX family members of Na+/Ca2+ exchangers is thus mainly related to changes in cytosolic [Na+] ([Na+]cyt) according to the following equation: [Ca2+]cyt = [Ca2+]out x ([Na+]cyt ÷ [Na+]out)3 x e(EmF/RT), where Em is the membrane potential, F is the Faraday constant, R is the gas constant, T is the absolute temperature, and "out" and "cyt" indicate extracellular or cytosolic concentrations of Ca2+ or Na+, respectively. The equation indicates that, when extracellular [Ca2+] and [Na+] are maintained constant, [Ca2+]cyt is positively proportional to the third power of [Na+]cyt. That is, a small increase in intracellular [Na+] can significantly increase [Ca2+]cyt due to the reverse mode of Na+/Ca2+ exchange (9, 29, 63).
In addition to voltage-gated Na+ channels (28, 45), human PASMC (30, 60, 62) also express transient receptor potential (TRP) channels that form functional cation channels allowing both Na+ and Ca2+ to enter cell (8, 13, 24). Therefore, TRP channels may serve as a critical pathway for increasing [Na+]cyt, when cells are stimulated by mitogenic agonists and vasoactive substances (4, 10, 11, 47). The resultant activation of the reverse mode of Na+/Ca2+ exchange (as a result of increased [Na+]cyt) would thus function as an additional pathway for elevating [Ca2+]cyt in PASMC. Since the Na+/Ca2+ exchanger is functionally coupled to the sarcoplasmic reticulum (SR) or endoplasmic reticulum (ER) Ca2+-Mg2+ ATPase (SERCA) (31), the accumulated Ca2+ due to Ca2+ entry via Na+/Ca2+ exchanger would be easily and efficiently sequestered to the SR/ER by SERCA and thereby increasing [Ca2+] in the SR/ER ([Ca2+]SR/ER).
Activation of G protein-coupled receptors (GPCRs) or tyrosine kinase receptors leads to activation of phospholipase C (PLC-
and -
) and to synthesis of inositol-1,4,5-trisphosphate (IP3) and diacylglycerol. IP3 induces Ca2+ mobilization from the SR/ER by activating IP3 receptors (17, 22, 44), while diacylglycerol mediates Ca2+ influx by activating receptor-operated Ca2+ channels (ROC) in the plasma membrane (2, 16). Furthermore, the IP3-mediated store depletion opens store-operated Ca2+ channels (SOC) and further increases [Ca2+]cyt by promoting Ca2+ influx (8, 46, 55, 64). Therefore, a higher concentration of stored Ca2+ in the SR/ER may play an important role in triggering (and maintaining) the signaling cascade involved in agonist-induced vasoconstriction and mitogen-mediated PASMC proliferation (24, 63).
In this study, we examined and compared the protein expression of Na+/Ca2+ exchanger and the increase in [Ca2+]cyt due to the reverse mode of Na+/Ca2+ exchanger in PASMC from normal subjects and patients with idiopathic pulmonary arterial hypertension (IPAH). Our results indicate that 1) the reverse mode of Na+/Ca2+ exchange functions as an important pathway for regulating [Ca2+]cyt in normal human PASMC, 2) the store depletion-mediated Ca2+ entry is partially mediated by activating the reverse mode of Na+/Ca2+ exchange in normal PASMC, 3) the NCX1 isoform of Na+/Ca2+ exchanger proteins is upregulated and the increase in [Ca2+]cyt due to the reverse mode of Na+/Ca2+ exchange is enhanced in PASMC from IPAH patients compared with PASMC from normal subjects and control patients. The upregulated Na+/Ca2+ exchangers, along with the upregulated TRP channels in caveolae (42, 59), in PASMC may play an important pathogenic role in the development of sustained pulmonary vasoconstriction and severe pulmonary vascular remodeling in patients with IPAH.
| METHODS AND MATERIALS |
|---|
|
|
|---|
Peripheral muscular pulmonary arteries isolated from the explanted lung tissues were first incubated in Hanks' balanced salt solution that contained 2 mg/ml collagenase (Worthington Biochemical) for 20 min to remove adventitia by a fine forceps and to remove endothelium by a surgical scalpel (61). The remaining smooth muscle was then digested for 40–50 min with (in mg/ml) 2.25 collagenase, 0.5 elastase, and 1 albumin (Sigma) at 37°C to make a cell suspension of PASMC. The cells were resuspended in the smooth muscle growth medium (SmGM, Cambrex) and cultured in an incubator under a humidified atmosphere of 5% CO2-95% air at 37°C. The cells from normotensive patients and IPAH patients were split into new petri dishes when 70–90% confluence was achieved to amplify cell numbers. The subcultured cells were then stored at –80°C and used at passages 4–7 for molecular biological and fluorescence microscopy experiments.
Human PASMC from normal subjects were also cultured in SmGM and used at passages 4–6 for experimentation. The medium was changed after 24 h and every 48 h thereafter. The SmGM was composed of smooth muscle basal medium supplemented with 5% fetal bovine serum, 0.5 ng/ml human epidermal growth factor, 2 ng/ml human fibroblast growth factor, and 5 µg/ml insulin. Cells were subcultured or plated onto 25-mm coverslips using trypsin-EDTA buffer (Cambrex) when 70–90% confluence was achieved.
Western blot analysis. Cells were gently washed twice in cold PBS, scraped into 0.3 ml of radioimmunoprecipitation assay buffer [1x PBS, 1% Nonidet P-40 (Amaresco), 0.5% sodium deoxycholate, and 0.1% SDS], and incubated on ice for 45 min. The cell lysates were sonicated and centrifuged at 14,000 rpm for 15 min at 4°C. The supernatants were collected, and protein concentration was determined by Coomassie Plus protein assay reagent (Pierce Biotechnology) using BSA as a standard. Protein (30 µg) was mixed and boiled in 2x sample buffer (0.25 M Tris·HCl, pH 6.8, 20% glycerol, 8% SDS, and 0.02% bromophenol blue). Protein suspensions were electrophoretically separated on an 8% acrylamide gel, and protein bands were transferred to nitrocellulose membranes by electroblot in a Mini Trans-Blot cell transfer apparatus (Bio-Rad) under conditions recommended by the manufacturer. After 1 h of incubation in a blocking buffer (0.1% Tween 20 and 5% nonfat dry milk powder), the membranes were incubated with R3F1 monoclonal antibody against NCX1 (Swant, Bellinzona, Switzerland) diluted in blocking buffer (1:5,000) overnight at 4°C. Finally, the membranes were washed and exposed to anti-mouse horseradish peroxidase-conjugated IgG for 60 min at room temperature. The bound antibody was detected with an enhanced chemiluminescence detection system (Amersham). Negative control experiments for Western blot analysis were performed using only the secondary antibody; there was no detectable band on the membrane if the primary antibody (for NCX1) was not added (data not shown).
Immunofluorescence labeling. Human PASMC on slides were fixed in 4% paraformaldehyde for 20 min. After being blocked with 4% bovine serum albumin for 20 min, a specific monoclonal antibody against NCX1 (R3F1, Swant) was applied to the cells, followed by a secondary antibody conjugated with green fluorescence (Alexa Fluor 488; Molecular Probes). The cells were then stained with the membrane-permeable nucleic acid stain 4,6-diamidino-2-phenylindole (5 µM; Sigma), and the blue fluorescence (emitted at 461 nm) was used to detect cell nuclei. The cell images were processed by 3D deconvolution fluorescence microscopy with the SoftWorx (Applied Precision), and analyzed by Matlab (The MathWorks, Natick, MA).
Measurement of [Ca2+]cyt. [Ca2+]cyt in single human PASMC was measured using the Ca2+-sensitive fluorescent indicator fura 2-AM. Cells on 25-mm coverslips were loaded with fura 2-AM (3 µM) for 30 min, in the dark at room temperature (22–24°C) under an atmosphere of 5% CO2-95% air. The fura 2-AM-loaded cells were then transferred to a perfusion chamber on the microscope stage and superfused with modified Krebs solution for 30 min to remove extracellular dye and allow intracellular esterases to cleave cytosolic fura 2-AM into active fura 2. The modified Krebs solution contained (in mM) 140 NaCl, 4.7 KCl, 1.8 CaCl2, 1.2 MgCl2, 10 HEPES, and 10 glucose, pH 7.4. In Ca2+-free PSS, CaCl2 was replaced by equimolar MgCl2, and 0.1 mM EGTA was added to chelate residual Ca2+. In Na+-free PSS, NaCl was replaced by equimolar N-methyl-D-glucamine (NMDG+) or LiCl.
Fura 2 fluorescence (510-nm light emission excited by 340- and 380-nm illuminations) from the cells, as well as background fluorescence, was collected at room temperature (22°C) using a x40 Nikon UV-Fluor objective and a charge-coupled device camera. The fluorescence signals emitted from the cells were monitored continuously using an intracellular imaging fluorescence microscopy system and recorded in an IBM-compatible computer for later analysis. [Ca2+]cyt was calculated from fura 2 fluorescent emission excited at 340 and 380 nm (F340/F380) using the ratio method based on the equation [Ca2+]cyt = Kd x (Sf2 ÷ Sb2) x (R – Rmin) ÷ (Rmax – R), where Kd (225 nM) is the dissociation constant for Ca2+, R was the measured fluorescence ratio, Rmin and Rmax were minimal and maximal ratios, respectively.
Chemicals. Cyclopiazonic acid (CPA; Sigma) and KB-R7943 (Tocris, Ellisville, MO) were dissolved in DMSO to make a stock solution of 50–100 mM. Aliquots of the stock solution were then diluted 1:1,000–10,000 in PSS, Ca2+-free PSS, or Na+-free PSS, respectively, on the day of use to their final concentrations. All chemicals were of analytical grade or better.
Statistics. The composite data are expressed as means ± SE. Statistical analysis was performed using paired or unpaired Student's t-test or ANOVA and post hoc tests (Student-Newman-Keuls) where appropriate. Differences were considered to be significant at P < 0.05.
| RESULTS |
|---|
|
|
|---|
-actin were comparable in PASMC from IPAH patients and normal subjects and SPH patients (Fig. 1A, a and c). The protein expression level of NCX1 in PASMC from normal subjects and SPH patients were comparable to the expression level in lung tissues from normotensive patients with COPD (Fig. 1Ab). In addition, the immunocytochemical experiments also indicate that NCX1 protein level was higher in IPAH PASMC than in normal PASMC (Fig. 1B).
|
|
|
Store-operated Na+ influx contributes to the [Ca2+]cyt increase due to activation of the reverse mode of Na+/Ca2+ exchange in normal and IPAH PASMC. The transmembrane Na+ gradient can be changed by a local increase in [Na+]cyt due to Na+ influx through Na+-permeable channels, such as voltage-gated Na+ channels (6, 14, 39, 45, 48) and TRP channels (19, 20, 41). In human PASMC superfused with Ca2+-free solution (0 Ca), inhibition of the SR/ER Ca2+ pump (SERCA) with CPA (10 µM), first caused a rapid increase in [Ca2+]cyt due to Ca2+ leakage from the SR/ER to the cytosol (Fig. 4A, left). The mobilized Ca2+ was then extruded by Ca2+ pumps and Na+/Ca2+ exchangers (in the forward mode) in the plasma membrane. After CPA-mediated Ca2+ mobilization from the SR/ER was complete, restoration of extracellular Ca2+ caused an additional increase in [Ca2+]cyt due apparently to capacitative Ca2+ entry (CCE) (Fig. 4A, left, shadowed box) or Ca2+ influx through SOCs.
|
Passive depletion of intracellular Ca2+ stores with CPA caused an increase in [Ca2+]cyt due to Ca2+ influx through SOC, usually referred to as capacitative Ca2+ entry, in normal PASMC (Fig. 4A, left). Treatment of the cells with small interfering (si)RNA specifically targeting NCX1, however, caused a 56% reduction of the amplitude of store depletion-mediated Ca2+ entry, while the resting [Ca2+]cyt level and the amplitude of CPA-mediated Ca2+ leakage or release were not significantly affected by NCX1-siRNA treatment (Fig. 4, A and B). These results indicate that the store depletion-mediated [Ca2+]cyt increase is 1) partially caused by the store-operated Ca2+ influx through SOC or CCE, and 2) partially caused by Ca2+ entry through the reverse mode of Na+/Ca2+ exchange, which is activated by store depletion-mediated Na+ influx via TRP channels and subsequent increase in local [Na+]cyt. Removal of extracellular Na+ or inhibition of the reverse mode of Na+/Ca2+ exchange significantly inhibited store depletion-mediated increase in [Ca2+]cyt (63). In other words, the store depletion-mediated rise in [Ca2+]cyt (e.g., induced by CPA) is significantly inhibited in PASMC superfused with Na+-free solution compared with PASMC superfused with 140 mM Na+-containing solution (63). These observations further suggest that store depletion-mediated [Ca2+]cyt increase results from both Ca2+ influx through SOC (or CCE) and Ca2+ entry via the reverse mode of Na+/Ca2+ exchange.
When PASMC are superfused with Na+-free solution, store depletion-mediated opening of TRP channels or SOC would be unable to raise [Na+]cyt and activate the reverse mode of Na+/Ca2+ exchange. Therefore, store depletion-mediated increase in [Ca2+]cyt in PASMC superfused with Na+-free solution would be due solely to Ca2+ influx through SOC (or TRP channels) or CCE. The next set of experiments was designed to examine whether store depletion-mediated Ca2+ influx through SOC (i.e., CCE) independent of the Ca2+ entry via Na+/Ca2+ exchange was also augmented in PASMC from IPAH patients.
As shown in Fig. 5, the CPA-mediated Ca2+ mobilization (or release) from the intracellular stores in PASMC bathed in Ca2+-free and Na+-free solution was increased in patients with IPAH (Fig. 5, A and B), indicating that [Ca2+] in the SR/ER is higher in IPAH PASMC than normal PASMC. Furthermore, the rise in [Ca2+]cyt due to store depletion-mediated Ca2+ influx through SOC (or CCE) in IPAH PASMC (523.6 ± 27.5 nM; n = 33 cells) was
81% higher than that in normal PASMC (288.8 ± 13.0 nM; n = 36 cells; P < 0.001) (Fig. 5, A and B). These results are consistent with our previously published data showing that 1) TRPC channels (e.g., TRPC3 and TRPC6) are upregulated and 2) CPA-mediated CCE (i.e., Ca2+ influx through SOC) is enhanced in PASMC from IPAH patients (59).
|
3.3x the amplitude in IPAH PASMC bathed in 140 mM Na+-containing solution (192.5 ± 12.6 nM, n = 37; P < 0.001). These results not only present additional indirect evidence that the activity of the reverse mode of Na+/Ca2+ exchange is augmented in IPAH PASMC, but also suggest that NCX1 may be functionally coupled and physically close to TRPC channels in the plasma membrane and SERCA in the SR/ER membrane (5, 9, 23, 31, 36).
Nevertheless, the amplitude of [Ca2+]cyt rise due to store depletion-mediated Ca2+ entry in IPAH-PASMC bathed in Na+-free solution (523.6 ± 27.5 nM, n = 66 cells) was
30% less than the amplitude in IPAH-PASMC bathed in 140 mM Na+-containing solution (728.7 ± 10.3 nM, n = 37 cells; P < 0.001) (Fig. 5C). These data also imply that the inward transportation of Ca2+ via the reverse mode of Na+/Ca2+ exchange accounts for about one-third to one-fourth of the total Ca2+ entry induced by CPA-mediated passive depletion of intracellular stores.
| DISCUSSION |
|---|
|
|
|---|
The results from this study demonstrate that human PASMC functionally express Na+/Ca2+ exchangers, e.g., NCX1 (63); removal of extracellular Na+ increases [Ca2+]cyt in PASMC by activating the reverse mode of Na+/Ca2+ exchange. Furthermore, the store depletion-mediated Ca2+ entry is caused by at least two mechanisms: 1) CCE, through Ca2+ release-activated Ca2+ channels, SOC, and/or TRP channels (2, 40); and 2) inward transportation of Ca2+ via the reverse mode of Na+/Ca2+ exchange, which is triggered by a local rise in [Na+]cyt due to store depletion-mediated Na+ influx through TRP-encoded SOC. These observations indicate that, in normal PASMC, agonist- or mitogen-mediated Ca2+ release from the SR (due to IP3-mediated activation of IP3 receptors) causes store depletion, which induces not only Ca2+ influx but also Na+ influx through TRP-encoded SOC. The subsequent rise in [Na+]cyt reverses the driving force for Na+/Ca2+ exchange (from the forward mode to the reverse mode), and ultimately enhances inward transportation of Ca2+ through the reverse mode of Na+/Ca2+ exchange as shown in Fig. 6) .
|
In PASMC from IPAH patients, we previously reported that mRNA and protein expression of TRPC3 and TRPC6 were upregulated compared with PASMC from normal subjects and patients with normotensive cardiopulmonary diseases and secondary pulmonary hypertension (e.g., due to chronic obstructive pulmonary disease and emphysema, interstitial pulmonary fibrosis) (59). The data from the current study indicate that protein expression of NCX1 is also upregulated in PASMC from IPAH patients. Interestingly, the upregulated NCX1 appear to function mainly in the reverse mode because the Ca2+ extrusion due to the forward mode of Na+/Ca2+ exchange in the presence of high extracellular Na+ is not enhanced in IPAH PASMC. However, the inward transportation of Ca2+ through the reverse mode of Na+/Ca2+ exchange, induced by either removal of extracellular Na+ or by CPA-induced passive store depletion, was augmented in PASMC from IPAH patients. These results suggest that upregulated TRPC channels and Na+/Ca2+ exchangers interact functionally with each other in submembrane vicinity close to caveolae in PASMC from IPAH patients to magnify agonist-mediated smooth muscle contraction and mitogen-mediated PASMC proliferation and migration. Indeed, our recent data indicate that mRNA and protein expression of caveolin and number of caveolae in IPAH-PASMC are much greater than those in normal PASMC and PASMC from patients with secondary pulmonary hypertension (42). Treatment of IPAH-PASMC with methyl-
-cyclodextrin (M
CD), a compound that depletes membrane cholesterol and disrupts caveolae, and with siRNA for caveolin-1 resulted in a concentration-dependent decrease in store depletion-mediated Ca2+ entry (42). The functional and physical colocalization of receptors and TRPC channels in caveolae by caveolin have also been implicated in systemic arterial smooth muscle cells (5).
As mentioned earlier, the TRP channels that participate in forming SOC or ROC are nonselective cation channels. On the basis of the permeation studies, the permeability for Na+ is actually greater than Ca2+ for many TRP isoforms (8, 24). Therefore, upon activation of receptors in the plasma membrane in PASMC, when TRP channels are opened, either by store depletion (for SOC) or diacylglycerol and PKC (for ROC), both Ca2+ and Na+ can, competitively, go through the channels and enter cell. In the case of that TRP channels and Na+/Ca2+ exchangers are both upregulated, such as in PASMC from IPAH patients, if opened TRP channels (formed in either SOC or ROC) predominantly allow Ca2+ to enter cell, it would directly contribute to increasing [Ca2+]cyt. However, if opened, TRP channels predominantly allow Na+ to go through and enter cell, the increased Na+ influx or increased accumulation of Na+ in the area close to Na+/Ca2+ exchange proteins would indirectly raise [Ca2+]cyt by activating inward transportation of Ca2+ through the reverse mode of Na+/Ca2+ exchange. The remaining question is whether and how extracellular Na+ competes with Ca2+ for opened TRP channels, and whether TRP channels have a "special" mode to recognize Na+ vs. Ca2+.
In cells transfected with TRPC channels, the Na+ currents through these channels seem to have higher amplitude (which is obviously due to the channels' higher permeability) than the Ca2+ currents. Removal of extracellular Na+, however, significantly enhances the amplitude of Ca2+ currents, indicating that Na+ and Ca2+ do compete with each other to get into the pore of TRPC channels (19). The ion permeability among different TRP channels seem to be dramatically different (19). These may also indicate that the functional heterotetrameric TRP channels existing in native cells may have very different permeability to Na+ and Ca2+. In IPAH, upregulation of certain TRPC isoforms may alter the composition of heterotetrameric TRP channels in PASMC, change the relative permeability of the functional channels to Na+ and Ca2+, and enhance Ca2+ entry via direct Ca2+ influx through the channels and via indirect Ca2+ entry through the reverse mode of Na+/Ca2+ exchange. Furthermore, it is unclear whether and how NCX1 and TRPC3/6 interact functionally in PASMC from IPAH patients, although they may both colocalize in caveolae by caveolins (3, 5, 19, 33, 47, 53).
In summary, circulating mitogenic factors in blood can penetrate into the smooth muscle layer in the pulmonary vasculature when endothelium is injured and/or endothelial barrier dysfunction takes place (34, 51). In addition, mitogenic factors synthesized and released from endothelial cell, smooth muscle cells and fibroblasts (as well as activated macrophages and platelets entrapped in extracellular matrix) can also activate receptors on the plasma membrane in PASMC via an autocrine or paracrine mechanism (15, 18, 25, 26, 58, 60). In PASMC from IPAH patients, contractile and mitogenic factors may accumulate in microdomains of the plasma membrane, such as caveolae, and consistently stimulate membrane receptors and their downstream signal transduction cascade. One of the downstream signaling pathways of GPCRs and receptor tyrosine kinase, when activated by mitogenic ligands, is to increase [Ca2+]cyt. With upregulated NCX1 (this study) and TRPC channels (43, 59), the mitogen- or agonist-mediated Ca2+ entry can be markedly enhanced in PASMC from IPAH patients. Selective blockade of the reverse mode of Na+/Ca2+ exchange and specific downregulation of NCX1, in combination with selective inhibition of TRPC channels (e.g., TRPC3 and TRPC6), would be a potential therapeutic strategy for patients with severe pulmonary hypertension, such as patients with familial and idiopathic pulmonary arterial hypertension.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
* S. Zhang and H. Dong contributed equally to this work. ![]()
| REFERENCES |
|---|
|
|
|---|
2. Albert AP, Large WA. Signal transduction pathways and gating mechanisms of native TRP-like cation channels in vascular myocytes. J Physiol 570: 45–51, 2006.
3. Ambudkar IS, Brazer SC, Liu X, Lockwich T, Singh B. Plasma membrane localization of TRPC channels: role of caveolar lipid rafts. Novartis Found Symp 258: 63–70, 2004.[Medline]
4. Arnon A, Hamlyn JM, Blaustein MP. Na+ entry via store-operated channels modulates Ca2+ signaling in arterial myocytes. Am J Physiol Cell Physiol 278: C163–C173, 2000.
5. Bergdahl A, Gomez MF, Dreja K, Xu SZ, Adner M, Beech DJ, Broman J, Hellstrand P, Sward K. Cholesterol depletion impairs vascular reactivity to endothelin-1 by reducing store-operated Ca2+ entry dependent on TRPC1. Circ Res 93: 839–847, 2003.
6. Berra-Romani R, Blaustein MP, Matteson DR. TTX-sensitive voltage-gated Na+ channels are expressed in mesenteric artery smooth muscle cells. Am J Physiol Heart Circ Physiol 289: H137–H145, 2005.
7. Berridge MJ. Calcium signalling and cell proliferation. Bioessays 17: 491–500, 1995.[CrossRef][Web of Science][Medline]
8. Birnbaumer L, Zhu X, Jiang M, Boulay G, Peyton M, Vannier B, Brown D, Platano D, Sadeghi H, Stefani E, Birnbaumer M. On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc Natl Acad Sci USA 93: 15195–15202, 1996.
9. Blaustein MP, Lederer WJ. Sodium/calcium exchange: its physiological implications. Physiol Rev 79: 763–854, 1999.
10. Borin ML, Tribe RM, Blaustein MP. Increased intracellular Na+ augments mobilization of Ca2+ from SR in vascular smooth muscle cells. Am J Physiol Cell Physiol 266: C311–C317, 1994.
11. Bova S, Goldman WF, Yuan XJ, Blaustein MP. Influence of Na+ gradient on Ca2+ transients and contraction in vascular smooth muscle. Am J Physiol Heart Circ Physiol 259: H409–H423, 1990.
12. Cioffi DL, Wu S, Stevens T. On the endothelial cell ISOC. Cell Calcium 33: 323–336, 2003.[CrossRef][Web of Science][Medline]
13. Clapham DE. TRP channels as cellular sensors. Nature 426: 517–524, 2003.[CrossRef][Medline]
14. Cox RH, Zhou Z, Tulenko TN. Voltage-gated sodium channels in human aortic smooth muscle cells. J Vasc Res 35: 310–317, 1998.[CrossRef][Web of Science][Medline]
15. Day RM, Agyeman AS, Segel MJ, Chévere RD, Angelosanto JM, Suzuki YJ, Fanburg BL. Serotonin induces pulmonary artery smooth muscle cell migration. Biochem Pharmacol 71: 386–397, 2006.[CrossRef][Web of Science][Medline]
16. Dietrich A, Kalwa H, Rost BR, Gudermann T. The diacylgylcerol-sensitive TRPC3/6/7 subfamily of cation channels: functional characterization and physiological relevance. Pflügers Arch 451: 72–80, 2005.[CrossRef][Web of Science][Medline]
17. Doi S, Damron DS, Horibe M, Murray PA. Capacitative Ca2+ entry and tyrosine kinase activation in canine pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278: L118–L130, 2000.
18. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 84: 329–336, 1999.
19. Eder P, Poteser M, Romanin C, Groschner K. Na+ entry and modulation of Na+/Ca2+ exchange as a key mechanism of TRPC signaling. Pflügers Arch 451: 99–104, 2005.[CrossRef][Web of Science][Medline]
20. Estacion M, Sinkins WG, Jones SW, Applegate MAB, Schilling WP. Human TRPC6 expressed in HEK 293 cells forms non-selective cation channels with limited Ca2+ permeability. J Physiol 572: 359–377, 2006.
21. Fantozzi I, Zhang S, Platoshyn O, Remillard CV, Cowling RT, Yuan JX-J. Hypoxia increases AP-1 binding activity by enhancing capacitative Ca2+ entry in human pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 285: L1233–L1245, 2003.
22. Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med 6: 1221–1227, 2000.[CrossRef][Web of Science][Medline]
23. Ganitkevich VY, Isenberg G. Ca2+ entry through Na+-Ca2+ exchange can trigger Ca2+ release from Ca2+ stores in Na+-loaded guinea-pig coronary myocytes. J Physiol 468: 225–243, 1989.
24. Golovina VA, Platoshyn O, Bailey CL, Wang J, Limsuwan A, Sweeney M, Rubin LJ, Yuan JX-J. Upregulated TRP and enhanced capacitative Ca2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746–H755, 2001.
25. Hamilton JR, Moffatt JD, Frauman AG, Cocks TM. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries. J Cardiovasc Pharmacol 38: 108–119, 2001.[CrossRef][Web of Science][Medline]
26. Isenberg JS, Calzada MJ, Zhou L, Guo N, Lawler J, Wang XQ, Frazier WA, Roberts DD. Endogenous thrombospondin-1 is not necessary for proliferation but is permissive for vascular smooth muscle cell responses to platelet-derived growth factor. Matrix Biol 24: 110–123, 2005.[CrossRef][Web of Science][Medline]
27. Iwamoto T, Watano T, Shigekawa M. A novel isothiourea derivative selectively inhibits the reverse mode of Na+/Ca2+ exchange in cells expressing NCX1. J Biol Chem 271: 22391–22397, 1996.
28. James AF, Okada T, Horie M. A fast transient outward current in cultured cells from human pulmonary artery smooth muscle. Am J Physiol Heart Circ Physiol 268: H2358–H2365, 1995.
29. Kraev A, Quednau BD, Leach S, Li XF, Dong H, Winkfein R, Perizzolo M, Cai X, Yang R, Philipson KD, Lytton J. Molecular cloning of a third member of the potassium-dependent sodium-calcium exchanger gene family, NCKX3. J Biol Chem 276: 23161–23172, 2001.
30. Kunichika N, Yu Y, Remillard CV, Platoshyn O, Zhang S, Yuan JX-J. Overexpression of TRPC1 enhances pulmonary vasoconstriction induced by capacitative Ca2+ entry. Am J Physiol Lung Cell Mol Physiol 287: L962–L969, 2004.
31. Lee CH, Poburko D, Sahota P, Sandhu J, Ruehlmann DO, van Breemen C. The mechanism of phenylephrine-mediated [Ca2+]i oscillations underlying tonic contraction in the rabbit inferior vena cava. J Physiol 534: 641–650, 2001.
32. Lin MJ, Leung GPH, Zhang WM, Yang XR, Yip KP, Tse CM, Sham JSK. Chronic hypoxia-induced upregulation of store-operated and receptor-operated Ca2+ channels in pulmonary arterial smooth muscle cells: a novel mechanism of hypoxic pulmonary hypertension. Circ Res 95: 496–505, 2004.
33. Lockwich TP, Liu X, Singh BB, Jadlowiec J, Weiland S, Ambudkar IS. Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains. J Biol Chem 275: 11934–11942, 2000.
34. Lum H, Malik AB. Regulation of vascular endothelial barrier function. Am J Physiol Lung Cell Mol Physiol 267: L223–L241, 1994.
35. McDaniel SS, Platoshyn O, Wang J, Yu Y, Sweeney M, Krick S, Rubin LJ, Yuan JX-J. Capacitative Ca2+ entry in agonist-induced pulmonary vasoconstriction. Am J Physiol Lung Cell Mol Physiol 280: L870–L880, 2001.
36. Moore EDW, Etter EF, Philipson KD, Carrington WA, Fogarty KE, Lifshits LM, Fay FS. Coupling of the Na+/Ca2+ exchanger, Na+/K+ pump and sarcoplasmic reticulum in smooth muscle. Nature 365: 657–660, 1993.[CrossRef][Medline]
37. Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, Trembath RC. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-
1 and bone morphogenetic proteins. Circulation 104: 790–795, 2001.
38. Ogawa A, Nakamura K, Matsubara H, Fujio H, Ikeda T, Kobayashi K, Miyazaki I, Asanuma M, Miyaji K, Miura D, Kusano KF, Date H, Ohe T. Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Circulation 112: 1806–1812, 2005.
39. Okabe K, Kitamura K, Kuriyama H. The existence of a highly tetrodotoxin sensitive Na channel in freshly dispersed smooth muscle cells of the rabbit main pulmonary artery. Pflügers Arch 411: 423–428, 1988.[CrossRef][Web of Science][Medline]
40. Parekh AB, Putney JW Jr. Store-operated calcium channels. Physiol Rev 85: 757–810, 2005.
41. Park KS, Kim Y, Lee YH, Earm YE, Ho WK. Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ Res 93: 557–564, 2003.
42. Patel HH, Zhang S, Murray F, Niesman IR, Thistlethwaite PA, Farquhar MG, Yuan JX-J, Insel PA. Caveolae and caveolins regualte intracellular calcium in idiopathic pulmonary arterial hypertension: A potential therapeutic role for cholesterol-lowering drugs. Circulation 117: II-222, 2005.
43. Patel HH, Zhang S, Murray F, Thistlethwaite PA, Yuan JX-J, Insel PA. Cholesterol-depleting drugs, including statins, lower intracellular Ca2+ and inhibit proliferation in pulmonary artery smooth muscle cells in primary pulmonary hypertension (Abstract). FASEB J 19: A1665, 2005.
44. Pitt BR, Weng W, Steve AR, Blakely RD, Reynolds I, Davies P. Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol Lung Cell Mol Physiol 266: L178–L186, 1994.
45. Platoshyn O, Remillard CV, Fantozzi I, Sison T, Yuan J. Identification of functional voltage-gated Na+ channels in cultured human pulmonary artery smooth muscle cells. Pflügers Arch 451: 380–387, 2005.[CrossRef][Web of Science][Medline]
46. Putney JW Jr. A model for receptor-regulated calcium entry. Cell Calcium 7: 1–12, 1986.[CrossRef][Web of Science][Medline]
47. Rosker C, Graziani A, Lukas M, Eder P, Zhu MX, Romanin C, Groschner K. Ca2+ signaling by TRPC3 involves Na+ entry and local coupling to the Na+/Ca2+ exchanger. J Biol Chem 279, 2004.
48. Saleh S, Yeung SYM, Prestwich S, Pucovsky V, Greenwood IA. Electrophysiological and molecular identification of voltage-gated sodium channels in murine vascular myocytes. J Physiol 568: 155–169, 2005.
49. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231–236, 1994.[CrossRef][Medline]
50. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59: 89–144, 1997.[CrossRef][Web of Science][Medline]
51. Stevens T, Garcia JGN, Shasby DM, Bhattacharya J, Malik AB. Mechanisms regulating endothelial cell barrier function. Am J Physiol Lung Cell Mol Physiol 279: L419–L422, 2000.
52. Sweeney M, Yu Y, Platoshyn O, Zhang S, McDaniel SS, Yuan JX-J. Inhibition of endogenous TRP1 decreases capacitative Ca2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L144–L155, 2002.
53. Teubl M, Groschner K, Kohlwein SD, Mayer B, Schmidt K. Na+/Ca2+ exchange facilitates Ca2+-dependent activation of endothelial nitric-oxide synthase. J Biol Chem 274: 29529–29535, 1999.
54. Tiruppathi C, Freichel M, Vogel SM, Paria BC, Mehta D, Flockerzi V, Malik AB. Impairment of store-operated Ca2+ entry in TRPC4–/– mice interferes with increase in lung microvascular permeability. Circ Res 91: 70–76, 2002.
55. Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL. The cellular and molecular basis of store-operated calcium entry. Nat Cell Biol 4: E263–E272, 2002.[CrossRef][Web of Science][Medline]
56. Wang J, Shimoda LA, Sylvester JT. Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 286: L848–L858, 2004.
57. Wang J, Weigand L, Lu W, Sylvester JT, Semenza GL, Shimoda LA. Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells. Circ Res 98: 1528–1537, 2006.
58. Wharton J, Davie N, Upton PD, Yacoub MH, Polak JM, Morrell NW. Prostacyclin analogues differentially inhibit growth of distal and proximal human pulmonary artery smooth muscle cells. Circulation 102: 3130–3136, 2000.
59. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX-J. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci USA 101: 13861–13866, 2004.
60. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX-J. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316–C330, 2003.
61. Yuan JX-J, Aldinger AM, Juhaszova M, Wang J, Conte JV Jr, Gaine SP, Orens JB, Rubin LJ. Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension. Circulation 98: 1400–1406, 1998.
62. Zhang S, Remillard CV, Fantozzi I, Yuan JX-J. ATP-induced mitogenesis is mediated by CREB-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 287: C1192–C1204, 2004.
63. Zhang S, Yuan JX-J, Barrett KE, Dong H. Role of Na+/Ca2+ exchange in regulating cytosolic Ca2+ in cultured human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 288: C245–C252, 2005.
64. Zhu X, Jiang M, Peyton M, Boulay G, Hurst R, Stefani E, Birnbaumer L. trp, A novel mammalian gene family essential for agonist-activated capacitative Ca2+ entry. Cell 85: 661–671, 1996.[CrossRef][Web of Science][Medline]
This article has been cited by other articles:
![]() |
X. Dong, E. J. Smoll, K. H. Ko, J. Lee, J. Y. Chow, H. D. Kim, P. A. Insel, and H. Dong P2Y receptors mediate Ca2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion Am J Physiol Gastrointest Liver Physiol, February 1, 2009; 296(2): G424 - G432. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Ng, B. D. Kyle, A. R. Lennox, X.-M. Shen, W. J. Hatton, and J. R. Hume Cell culture alters Ca2+ entry pathways activated by store-depletion or hypoxia in canine pulmonary arterial smooth muscle cells Am J Physiol Cell Physiol, January 1, 2008; 294(1): C313 - C323. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Fellner and W. J. Arendshorst Angiotensin II-stimulated Ca2+ entry mechanisms in afferent arterioles: role of transient receptor potential canonical channels and reverse Na+/Ca2+ exchange Am J Physiol Renal Physiol, January 1, 2008; 294(1): F212 - F219. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |